Clinical trial
A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients
NCT00299338 · Samaritan Pharmaceuticals, Inc, Industry · Completed
Key facts
| NCT number | NCT00299338 |
|---|---|
| Title | A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients |
| Official title | A Pharmacokinetic and Safety Study of Procaine HCl in HIV-1 Infected Patients |
| Lead sponsor | Samaritan Pharmaceuticals, Inc, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | SP01A |
| Enrollment | 24 |
| Start date | Sep 1, 1997 |
| Completion | Sep 1, 2001 |
| First posted | Mar 6, 2006 |
| Last update posted | Apr 3, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: